Xenon Pharmaceuticals (XENE) Change in Receivables (2016 - 2025)
Historic Change in Receivables for Xenon Pharmaceuticals (XENE) over the last 13 years, with Q3 2025 value amounting to -$283000.0.
- Xenon Pharmaceuticals' Change in Receivables fell 44096.39% to -$283000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$116000.0, marking a year-over-year decrease of 13213.3%. This contributed to the annual value of $614000.0 for FY2024, which is 57230.77% up from last year.
- According to the latest figures from Q3 2025, Xenon Pharmaceuticals' Change in Receivables is -$283000.0, which was down 44096.39% from -$7.6 million recorded in Q2 2025.
- In the past 5 years, Xenon Pharmaceuticals' Change in Receivables registered a high of $7.2 million during Q1 2025, and its lowest value of -$7.6 million during Q2 2025.
- For the 5-year period, Xenon Pharmaceuticals' Change in Receivables averaged around -$77736.8, with its median value being -$38000.0 (2024).
- Examining YoY changes over the last 5 years, Xenon Pharmaceuticals' Change in Receivables showed a top increase of 1898947.37% in 2025 and a maximum decrease of 3445454.55% in 2025.
- Xenon Pharmaceuticals' Change in Receivables (Quarter) stood at -$481000.0 in 2021, then plummeted by 214.97% to -$1.5 million in 2022, then surged by 119.41% to $294000.0 in 2023, then skyrocketed by 86.05% to $547000.0 in 2024, then crashed by 151.74% to -$283000.0 in 2025.
- Its Change in Receivables was -$283000.0 in Q3 2025, compared to -$7.6 million in Q2 2025 and $7.2 million in Q1 2025.